New inhibitors of poly(ADP-ribose) polymerase and their potential therapeutic targets

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.7, 2002-07, pp. : 1047-1071

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New inhibitors of poly(ADP-ribose) polymerase (PARP)

By Peukert Stefan Schwahn Uwe

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. : 1531-1551

Informa Healthcare

Access to resources Recommend Favorite

Poly(ADP-Ribose) Polymerase Inhibitors

Current Medicinal Chemistry, Vol. 10, Iss. 4, 2003-01 ,pp. : 321-340

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP)-Ribose Polymerase-1 Inhibitors as a Potential Treatment for Cocaine Addiction

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-08 ,pp. : 727-730

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Free Radicals and Poly(ADP-Ribose)Polymerase-1 in the Development of Spinal Cord Injury: New Potential Therapeutic Targets

Current Medicinal Chemistry, Vol. 15, Iss. 5, 2008-02 ,pp. : 477-487

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications

Current Pharmaceutical Design, Vol. 13, Iss. 9, 2007-03 ,pp. : 933-962

Bentham Science Publishers

Access to resources Recommend Favorite